These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8494381)

  • 1. Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein.
    Erice A; Balfour HH; Myers DE; Leske VL; Sannerud KJ; Kuebelbeck V; Irvin JD; Uckun FM
    Antimicrob Agents Chemother; 1993 Apr; 37(4):835-8. PubMed ID: 8494381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 replication in seropositive patients' CD4+ T-cells by pokeweed antiviral protein-monoclonal antibody conjugates.
    Zarling JM; Moran PA; Haffar O; Diegel M; Myers DE; Kuelbeck V; Ledbetter JA; Uckun FM
    Int J Immunopharmacol; 1991; 13 Suppl 1():63-8. PubMed ID: 1688086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus.
    Uckun FM; Chelstrom LM; Tuel-Ahlgren L; Dibirdik I; Irvin JD; Langlie MC; Myers DE
    Antimicrob Agents Chemother; 1998 Feb; 42(2):383-8. PubMed ID: 9527790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.
    Zarling JM; Moran PA; Haffar O; Sias J; Richman DD; Spina CA; Myers DE; Kuebelbeck V; Ledbetter JA; Uckun FM
    Nature; 1990 Sep; 347(6288):92-5. PubMed ID: 1975641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40.
    Verhoef J; Gekker G; Erice A; Peterson PK; Balfour HH
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):715-21. PubMed ID: 1425730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribosomal inhibitory proteins from plants inhibit HIV-1 replication in acutely infected peripheral blood mononuclear cells.
    Olson MC; Ramakrishnan S; Anand R
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):1025-30. PubMed ID: 1725958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pokeweed antiviral protein isoforms PAP-I, PAP-II, and PAP-III depurinate RNA of human immunodeficiency virus (HIV)-1.
    Rajamohan F; Venkatachalam TK; Irvin JD; Uckun FM
    Biochem Biophys Res Commun; 1999 Jul; 260(2):453-8. PubMed ID: 10403789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide.
    Jansen B; Kersey JH; Jaszcz WB; Gunther R; Nguyen DP; Chelstrom LM; Tuel-Ahlgren L; Uckun FM
    Leukemia; 1993 Feb; 7(2):290-7. PubMed ID: 7678881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoconjugates that neutralize HIV virions kill T cells infected with diverse strains of HIV-1.
    Kim YW; Fung MS; Sun NC; Sun CR; Chang NT; Chang TW
    J Immunol; 1990 Feb; 144(4):1257-62. PubMed ID: 2303707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies.
    Bolognesi A; Tazzari PL; Olivieri F; Polito L; Lemoli R; Terenzi A; Pasqualucci L; Falini B; Stirpe F
    Br J Haematol; 1998 Apr; 101(1):179-88. PubMed ID: 9576199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
    Uckun FM; Manivel C; Arthur D; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Irvin JD; Myers DE; Gunther R
    Blood; 1992 May; 79(9):2201-14. PubMed ID: 1373967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells.
    Waddick KG; Myers DE; Gunther R; Chelstrom LM; Chandan-Langlie M; Irvin JD; Tumer N; Uckun FM
    Blood; 1995 Dec; 86(11):4228-33. PubMed ID: 7492781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus.
    Uckun FM; Bellomy K; O'Neill K; Messinger Y; Johnson T; Chen CL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1301-7. PubMed ID: 10565855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 replication in vitro by the bisheteroarylpiperazine atevirdine (U-87201E) in combination with zidovudine or didanosine.
    Campbell TB; Young RK; Eron JJ; D'Aquila RT; Tarpley WG; Kuritzkes DR
    J Infect Dis; 1993 Aug; 168(2):318-26. PubMed ID: 7687641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine.
    Richman D; Rosenthal AS; Skoog M; Eckner RJ; Chou TC; Sabo JP; Merluzzi VJ
    Antimicrob Agents Chemother; 1991 Feb; 35(2):305-8. PubMed ID: 1708976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity.
    Uckun FM; Rajamohan F; Pendergrass S; Ozer Z; Waurzyniak B; Mao C
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1052-61. PubMed ID: 12604541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.
    Edlin BR; St Clair MH; Pitha PM; Whaling SM; King DM; Bitran JD; Weinstein RA
    Ann Intern Med; 1992 Sep; 117(6):457-60. PubMed ID: 1503348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable pharmacodynamic features and superior anti-leukemic activity of B43 (anti-CD19) immunotoxins containing two pokeweed antiviral protein molecules covalently linked to each monoclonal antibody molecule.
    Myers DE; Yanishevski Y; Masson E; Irvin JD; Evans WE; Uckun FM
    Leuk Lymphoma; 1995 Jun; 18(1-2):93-102. PubMed ID: 8580835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
    Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
    Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide.
    Uckun FM; Chelstrom LM; Finnegan D; Tuel-Ahlgren L; Manivel C; Irvin JD; Myers DE; Gunther R
    Blood; 1992 Jun; 79(12):3116-29. PubMed ID: 1375841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.